Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP46A1 | Q9Y6A2 | 3/20 | 1.00 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.83 |
| ▸ | POLA1 | P09884 | 1/20 | 0.74 |
| ▸ | OSBP | P22059 | 3/20 | 0.71 |
| ▸ | USP2 | O75604 | 2/20 | 0.71 |
| ▸ | RORC | P51449 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.71 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.71 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.63 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.63 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.63 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.63 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.61 |
| ▸ | GBA1 | P04062 | 2/20 | 0.60 |
| ▸ | UGCG | Q16739 | 2/20 | 0.60 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.60 |
| ▸ | NPC1L1 | Q9UHC9 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16248291 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL2304848 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL161397 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL3509637 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL25063545 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL25063542 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL192029 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL21334348 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL21824301 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL29094045 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200188353-A1 | Pharmaceutical Composition for Prevention or Treatment of Bone-Related Disease | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200188353-A1 | Pharmaceutical Composition for Prevention or Treatment of Bone-Related Disease | SOST, ACP3, BMP2 | CYP46A1 173/4885NR1H3 70/4885POLA1 4325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.